KLF4, SOX2, and NANOG had low expressions in tumor tissue compared with its adjacent non-malignant (NM) counterpart, while no significant changes were found for c-MYC and OCT4 gene expressions (Figure 1). This evidence concerns the gene KLF4 and neoplasm.